Firefly Neuroscience (AIFF) Debt to Equity (2020 - 2025)
Firefly Neuroscience has reported Debt to Equity over the past 6 years, most recently at $0.04 for Q2 2025.
- Quarterly results put Debt to Equity at $0.04 for Q2 2025, up 116.0% from a year ago — trailing twelve months through Jun 2025 was $0.04 (up 116.0% YoY), and the annual figure for FY2024 was -$1.85, changed.
- Debt to Equity for Q2 2025 was $0.04 at Firefly Neuroscience, up from -$1.85 in the prior quarter.
- Over the last five years, Debt to Equity for AIFF hit a ceiling of $0.42 in Q1 2023 and a floor of -$55.56 in Q1 2024.
- Median Debt to Equity over the past 5 years was -$0.19 (2022), compared with a mean of -$5.24.
- Biggest five-year swings in Debt to Equity: crashed 13273.99% in 2024 and later surged 116.0% in 2025.
- Firefly Neuroscience's Debt to Equity stood at $0.14 in 2021, then plummeted by 234.12% to -$0.19 in 2022, then tumbled by 154.75% to -$0.49 in 2023, then plummeted by 280.5% to -$1.85 in 2024, then skyrocketed by 102.13% to $0.04 in 2025.
- The last three reported values for Debt to Equity were $0.04 (Q2 2025), -$1.85 (Q4 2024), and -$0.25 (Q2 2024) per Business Quant data.